Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: We agree with the perspective
of Drs Merchant and Mayer in their Commentary1 that
the new Centers for Disease Control and Prevention (CDC) guidelines for provision
of human immunodeficiency virus (HIV) nonoccupational postexposure prophylaxis
(HIV NPEP)2 represents an important initial
step in advising clinicians. However, we note an important caveat with regard
to the choice of antiretroviral agents, as discussed in the clinical guidelines
developed by the New York State Department of Health AIDS Institute (NYSDOH
AI) in 1997 and updated in December 2004.3,4
Weinberg GA, Luque AE, Brown ST. Nonoccupational HIV Postexposure Prophylaxis. JAMA. 2005;294(13):1615–1616. doi:10.1001/jama.294.13.1615-a
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: